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A B S T R A C T
Patients of 50 years or older account for a small but signiﬁcant portion of the patient population that
receives surgical treatment for epilepsy. There have been few studies reporting surgical outcomes from
temporal lobectomy in older patients. We examined seizure outcome and surgical complications after
anterior temporal lobectomy for temporal lobe epilepsy with pathological evidence of unilateral
hippocampal sclerosis. Two patient groups were compared in this study: patients 50 years or older
(mean age 55.5 years old, n = 16) and patients less than 50 years old (mean age 32.9 years old, n = 184).
After aminimumof one year followup, younger patients (79.4%, n = 146)were signiﬁcantlymore likely
to be seizure-free (p = 0.041) compared to older patients (56.3%, n = 9). There was no signiﬁcant
difference (p = 0.404) between the two age groups in the percentage of patients withdrawn from
medication following surgery. Surgical complications were signiﬁcantly higher in the older age group
compared to the younger age group (p = 0.009), although there was no permanent morbidity. Thus,
while surgical treatment of temporal lobe epilepsy with unilateral hippocampal sclerosis is still
beneﬁcial in older patients who are refractory to medical therapy, surgical treatment should be
considered at as early an age as possible, to maximize the chance for a better outcome with fewer
complications.
 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Temporal lobectomy for medically refractory temporal lobe
epilepsy (TLE) can result in a patient becoming seizure-free.1 Older
adult patients account for a very small percentage of patients who
receive surgical treatment for epilepsy. Previous studies of surgical
outcome for the elderly have included various etiologies and have
shown comparable or less favorable outcomes than for younger
adults.2–7
The aim of this study was to evaluate the seizure outcome in
patients of 50 years of age and older undergoing temporal
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We retrospectively reviewed patients who had undergone
surgical treatment at King Chulalongkorn Memorial Hospital
between January 2004 and March 2009 for temporal lobe epilepsy
that was medically refractory. Study inclusion criteria consisted of
patients who were 16 years or older, had unilateral hippocampal
sclerosis that was pathologically conﬁrmed and no other lesions
detectable on magnetic resonance imaging (MRI). All patients had
a minimum of 1-year follow-up.
2.2. Preoperative evaluation
All patients underwent a complete neurological history and
physical examination, MRI and 24-h scalp video electroencepha-vier Ltd. All rights reserved.
Table 1
Patient’s demographics.
Variable Patients<50 year n/N (%); mean SD (range) Patients50 year n/N (%); mean SD (range) p-Value
Sex 0.243a
Male 87/184 (47.28%) 10/16 (62.50%)
Female 97/184 (52.72%) 6/16 (37.50%)
Onset of seizure (years) 13.107.70 (0.25–39) 24.6918.19 (1–60) 0.019c
Duration of seizure (years) 20.078.90 (1–44) 30.8116.01 (7–52) 0.010c
Age of surgery (years) 32.898.15 (6–49) 55.55.77 (50–72)
Febrile seizure 122/184 (66.30%) 8/16 (50.00%) 0.190a
Side of surgery 0.324a
Right 80/184 (43.48%) 9/16 (56.25%)
Left 104/184 (56.52%) 716 (43.75%)
Seizure types
Auras 142 (77.17%) 11 (68.75%) 0.538b
Complex partial seizures 174 (94.57%) 15 (93.75%) 1.000b
Generalized seizures 141 (76.63%) 11 (68.75%) 0.542b
Noninvasive EEG ﬁndings
Concord. interictal + ictal EEG 117 (63.59%) 8 (50%) 0.282b
Concord. ictal EEG only 38 (20.65%) 7 (43.75%) 0.055b
Concord. interictal EEG only 10 (5.43%) 1 (6.25%) 1.000b
Discord. interictal + ictal EEG 19 (10.33%) 0 (0%) 0.373b
Off antiepileptic medications 56/184 (30.43%) 3/16 (18.75%) 0.404b
Length of follow-up (years) 2.851.43 (1–6) 2.521.43 (1–5.5) 0.333c
a Pearson chi-square (df =1).
b Fisher exact test.
c Mann–Whitney U. Concord. Interictal EEG, >90% of interictal EEG ipsilateral to hippocampal sclerosis; Concord. ictal EEG, ictal EEG onset concordant with hippocampal
sclerosis; Discord. interictal + ictal EEG,<90% of interictal EEG ipsilateral to hippocampal sclerosis and ictal EEG onset discordant with hippocampal sclerosis or nonlocalized.
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tomography (SPECT) and positron emission tomography (PET)
were performed on selected patients.
2.3. Surgical procedures
All patients in the study underwent anterior temporal
lobectomy. The procedure includes amygdalohippocampectomy
and the resection of the anterior temporal neocortex (4–5 cm from
the temporal tip in the non-dominant hemisphere and a 3–4 cm in
the dominant hemisphere). Invasive monitoring with implanted
subdural electrodes was performed whenever noninvasive record-
ings were discordant. All surgery was performed by a single
neurosurgeon and all resected specimens underwent pathologic
examination.
2.4. Outcome assessment
Data were retrieved from the institutional epilepsy data bank,
which documents outpatient clinic visits. Seizure outcome was
classiﬁed according to Engel’s classiﬁcation8 based on the last
postoperative seizure. Patients were designated as ‘seizure-free’ if
in Engel class 1 or ‘not seizure-free’ if in Engel classes 2–4.
Complications related to surgery were compiled for the study
except superior quadrantanopsia, which was not considered a
complication.
2.5. Statistical analysis
The Pearson chi-square, Fisher’s exact test or Mann–Whitney U
test (when appropriate) were used to test for signiﬁcantTable 2
Univariate analysis of seizure outcome.
Patients<50 year n/N (%) Patien
Seizure outcome
Seizure free 146/184 (79.35%) 9/16
Not seizure free 38/184 (20.65%) 7/16
* Seizure outcome was statistically signiﬁcant (p<0.05) between the two age groupdifferences between two age groups: below 50 years and 50 years
or older. Univariate analysis was used to compare the seizure
outcome between these two groups and factors associated with
outcome. Results were considered to be statistically signiﬁcant
when the p value was less than 0.05.
3. Results
3.1. Demographic data
A total of 200 patients fulﬁlled the inclusion criteria. Sixteen
patients were older than 50 years (mean age, 55.5 years; age range,
50–72 years) and 184 patients were younger than 50 years (mean
age 32.9 years; age range, 16–49 years). There was no signiﬁcant
difference in gender, side of surgery, length of follow-up or history
of febrile seizures between the two groups (Table 1).
The mean onset of seizure was 13.1 years in the below 50 age
group and 24.7 years in the older group (p = 0.019). The mean
duration of epilepsy prior to surgerywas 20.0 years in the below 50
age group and 30.8 years in the older age group (p = 0.010). In order
to determine independent predictors of outcome, we performed
univariate analysis for: gender, side of surgery, onset of seizure,
duration of epilepsy, age of surgery, and history of febrile seizures.
None of these parameters proved to be predictors associated with
outcome, although the duration of epilepsy had the trend of being
statistically signiﬁcant (p = 0.061).
3.2. Seizure outcome
Seventy-seven percent of all the studied patients were seizure-
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Seizure outcomes in the younger group were as follows: class 1 in
79.4%, class 2 in 9.2%, class 3 in 9.8%, and class 4 in 1.6% of patients.
Patients over the age of 50 years were less often seizure-free
following temporal lobectomy than those of younger age
(p = 0.041) (Table 2). Three patients in the older group (18.8%)
and 57 patients in the younger than 50 age group (31%) had
discontinued antiepileptic medication (p = 0.404).
3.3. Complications
Postoperative complications in the older age group were
signiﬁcantly higher than in the younger age group (p = 0.009).
Complications occurred in four older patients (25%) including
three cases of subdural hygroma (two patients underwent surgery
and one refused surgery) and one chronic subdural hematoma that
required surgery. Operative complications in the younger age
group occurred in 8 patients (4.4%) including one with meningitis,
one with diplopia, one case with CSF leak, two cases with
hemiparesis that resolved withinmonths, two cases with a remote
cerebellar hematoma not requiring surgical intervention and one
with a remote epidural hematoma that needed evacuation. There
was no permanent morbidity and no mortality in either age group.
4. Discussion
The seizure outcome of temporal lobectomy for hippocampal
sclerosis in our study is comparable to that in previous reports.9,10
In older patients, surgical treatment of TLE had a seizure-free
outcome comparable to younger patients.3,6,7 Sirven et al.4
reported freedom from seizures in 16 of 30 patients (53%) older
than 50 years who underwent temporal lobectomy. Cascino et al.2
reported 3 of 6 patients in the older patient group were seizure-
free after temporal lobe surgery. Grivas et al.6 reported no
difference in seizure-free outcome between their younger age
group and patients older than 50 years following surgery for TLE.
McLachlan et al.3 and Boling et al.7 found a comparable outcome
in older age and younger age groups although there was a trend
towards greater freedom from seizures in younger patients. The
limitation of these studies is the heterogeneous etiologies of TLE in
the patients included.
A recent study of surgical treatment for TLE from hippocampal
sclerosis in older patients with long-term follow-up found a
comparable seizure free rate in older patients (Engel 1 81%) and
young patients (Engel 1 83%).5 The demographic data of patients in
that study were similar to our study, plus all patients had
undergone a uniform surgical resection by the same surgeon. Our
study showed fewer patients seizure-free (Engel 1) in both the
older and younger age groups, but the follow-up period (a
minimum 1 year follow-up) in our study is shorter than that for
the other study (a minimum 5 year follow-up). Some initially non-
seizure-free patients may achieve freedom from seizures after
long-term follow-up.11,12 Thus, longer follow-up and larger
numbers of older patients may be needed to compare our series
to this other series.5 Patient selection may also account for the
differences.
There are conﬂicting results in the literature on whether the
duration of epilepsy affects outcome. Previous studies did not ﬁnd
any association between the duration of epilepsy and seizure-free
outcome in TLE patients older than 50 years7 nor in patients with
TLE from hippocampal sclerosis.5,13,14 In a study of surgical
outcome in patients with TLE from hippocampal sclerosis, Janszky
et al.15 found a longer epilepsy duration predicted a poorer long-
term outcome. In our study, duration of epilepsy was not a
predictor of seizure-free outcome but age at surgery was. The
duration of epilepsy in the older age groupwas signiﬁcantly longerthan the younger age group. A longer duration of epilepsymay lead
to a higher incidence of secondary epileptogenesis16 and can be
associated with chronic structural and functional abnormali-
ties.3,17 Thismay account for the slightly less successful outcome of
surgery in older patients. The data suggest that surgery should be
performed at an earlier age once patients have become refractory
to antiepileptic medications.
The complications of temporal lobectomy in the age group of
patients 50 years and older is reported to be low and comparable
to younger patients.3,5,7 Complications were mild and in most
cases transient. Boling et al.7 reported a 6% complication rate in
patients older than 50 years. Grivas et al.6 reported a 7.7%
complication rate with 3.8% permanent neurological deﬁcits after
surgery for TLE in elderly. Our 6% rate of surgical complication is
comparable to previous reports on epilepsy surgery.18,19 Ryden-
hag and Silander19 reported an 8.1% rate for minor complications
and 2.7% for major complications after temporal lobe resection
including mesial structures. Behrens et al.18 reported a 7.5% rate
for surgical complications and 4.7% for neurological complica-
tions after temporal lobe resection. In a Swedish multicenter
study, the risks ofmajor complications following epilepsy surgery
were higher for patients older than 35 years.19 In our series,
surgical complications in older patients were related to subdural
collections. Atrophic brain in the elderly may be a factor
predisposing to complications in this age group. However, there
was no mortality or permanent morbidity. Improvement in
neuroanesthesia, microsurgical techniques and postoperative
monitoring of patients has decreased themorbidity andmortality
in older patients.
5. Conclusion
Surgical treatment of TLE with hippocampal sclerosis in elderly
patients offers the chance of being seizure-free although less likely
than in younger patients at short-term follow-up. Older age is not a
contraindication to epilepsy surgery but the risks are higher than
for younger patients. Our data support the concept that once a
patient is refractory to medical antiepileptic treatment, surgery
should be performed at as young an age as possible to maximize
the chance for freedom from seizures.
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